Knudson et al identified factors associated with a poor response to recombinant Factor VIIa therapy in trauma patients. These can help to identify a patient who may benefit from additional or alternative therapy. The authors are from the University of California San Francisco, the United States Army Institute of Surgical Research and the University of Texas at Houston.

To read more or access our algorithms and calculators, please log in or register.